Development and Preclinical Studies of Broad-Spectrum Anti-Hiv Agent (3′r,4′r)-3-Cyanomethyl-4-Methyl-3′,4′-Di-O-(S)-Camphanoyl-(+)-Cis-Khellactone (3-Cyanomethyl-4-Methyl-Dck)

Journal of Medicinal Chemistry - United States

doi 10.1021/jm8003009